Explore the Agenda

8:00 am Check-In & Coffee

Track One

Track One: Opening Your First Early Access Program

9:00 am Workshop A: Expanded Access Programs 101 – Mastering the Fundamentals for Effective Patient Access

Director, Head of Global Medical Operational Excellence and Strategic Planning, Blueprint Medicines
Assoc Director EAP, Blueprint Medicines
  • Gaining a clear understanding of different types of pre-approval access programs and their purpose
  • Mapping the global EAP landscape and navigating basic regulatory and ethical requirements
  • Learning the key roles and responsibilities across clinical, regulatory, supply, and commercial functions

Track Two

Track Two: Advanced Challenges in Early Access Programs

9:00 am Workshop D: Timing & Risk Management in EAP Strategy

Senior Director - Medical Access, Global Oncology Medical Affairs, Daiichi Sankyo
  •  Preparing EAP infrastructure early without certainty of trial readouts or approvals
  • Balancing investment risk vs. readiness: how much to build before the data arrives
  • Understanding the real timelines for opening EAPs across different geographies
  • Creating flexible plans that allow quick go/no-go decisions aligned to pivotal data milestones

11:00 am Morning Break & Networking

12:00 pm Workshop B: Designing Your First Expanded Access Program from Strategy to Launch

Global Medical Affairs Head, Orchard Therapeutics
Vice President, Clinical Operations & Data Management, Orchard Therapeutics
  • Translating organizational goals into a practical EAP strategy tailored to your patient population
  • Balancing ethical considerations with trial integrity to determine optimal timing and access
  • Planning program scope, cross-functional coordination, and vendor engagement for smooth execution

12:00 pm Workshop E: Navigating Complex Ethical, Patient-Centric & Paid-for Challenges in EAPs

  • Balancing fairness and feasibility when demand for access exceeds available supply
  • Exploring ethical and operational challenges in paid-for EAP models, and understanding their implications for patient trust and regulatory compliance
  • Using digital platforms, registries, and AI-driven tools to bring greater transparency and consistency in patient selection
  • Managing expectations and communication with patients, physicians, and advocacy groups when programs evolve, wind down, or require difficult trade-offs

2:00 pm Lunch Break & Networking

3:00 pm Workshop C: Managing EAPs End-to-End: Practical Tools to Deliver Timely & Compliant Access

Senior Manager - Global Clinical Supply Chain, Takeda Pharmaceutical
  • Mastering operational steps from program initiation through supply planning, labelling, and logistics
  • Learning tactics for improving physician and site engagement to accelerating patient treatment
  • Understanding how to anticipate and mitigating common operational and regulatory challenges
  • Exploring strategies for program closure or transition to ensuring seamless patient access

3:00 pm Workshop F: Futureproofing EAPs for Sustainability & Scalability

Executive Director & Consultant - Expanded, Continued Access, Product Delivery, Clinical Trial Commercial Product Strategy & Pr, Eli Lilly & Co.
  •  Build frameworks for scaling programs consistently across countries and patient populations while maintaining compliance
  • Integrate EAPs into healthcare systems and leverage digital tools to enhance efficiency and monitoring
  • Examine governance models that balance oversight, quality, and flexibility in evolving regulatory landscapes
  • Learn approaches for optimizing vendor partnerships and internal resources for long-term program resilience

5:00 pm End of Workshop Day